An alternative to detect specific abnormalities (RUNX1::RUNX1T1, CBFB::MYH11, KMT2A (MLL) and MECOM (EVI1) gene fusions or myelodysplasia-related chromosome abnormalities) is fluorescence in situ hybridization. Here, KMT2A is linked to Myelodysplasia.